Skip to main content
. Author manuscript; available in PMC: 2020 Apr 2.
Published in final edited form as: Neurobiol Aging. 2018 Oct 5;74:213–224. doi: 10.1016/j.neurobiolaging.2018.09.029

Figure 6. Impact of 5-aza-2’-deoxycitidine (5-aza) on initiation and completion of perimenopause.

Figure 6.

A) Survival curve analysis indicated a non-significant acceleration to initiation of perimenopause in 5-aza-treated animals. B) 5-aza significantly accelerated progression through the perimenopausal transition to menopausal acyclicity (Mantel-Cox p= 0.0043 ; Gehan-Brewslow-Wilcoxon p= 0.006).